Jazz Pharmaceuticals (JAZZ) Divestments (2015)
Jazz Pharmaceuticals' (JAZZ) quarterly Divestments came in at $1.0 million in Q2 2015, down 96.97% quarter-over-quarter from $33.0 million in Q1 2015.
Jazz Pharmaceuticals (JAZZ) Divestments (2015) Analysis & Trends
Jazz Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $1.0 million for Q2 2015.
- On a quarterly basis, Divestments changed N/A year-over-year to $1.0 million in Q2 2015; TTM through Mar 2016 was $1.0 million, a 96.97% decrease from a year earlier, with the FY2022 full-year figure at $53.0 million, changed N/A from the prior year.
- Divestments declined to $1.0 million in Q2 2015 per JAZZ's latest filing, from $33.0 million in the prior quarter.
- Across five years, Divestments topped out at $33.0 million in Q1 2015 and bottomed at $1.0 million in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -32.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.00 Mn |
| Mar 31, 2015 | 33.00 Mn |